| Douglas Nance, | |
|
2600 N Broadway St, Pittsburg, KS 66762-2623 | |
| (620) 232-3066 | |
| Not Available |
| Full Name | Douglas Nance |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2600 N Broadway St, Pittsburg, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104234079 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 10987 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Douglas Nance, 2600 N Broadway St, Pittsburg, KS 66762-2623 Ph: (620) 232-3066 | Douglas Nance, 2600 N Broadway St, Pittsburg, KS 66762-2623 Ph: (620) 232-3066 |
News Archive
CNN examines comments made by GOP presidential hopeful Mitt Romney regarding the possible dollar savings that could result by repealing the health law, while the AP revisits his positions regarding the Massachusetts health law he signed while that state's governor. Also in the news, more on Rick Perry's Texas and where the candidates state on health research.
Indiana University has been awarded $9.2 million from the National Science Foundation to lead two high-speed international network services. The awards provide IU with $4.6 million to continue the TransPAC3 network connection to Asia, and an additional $4.6 million for a new connection to Europe, named ACE - America Connects to Europe.
The Robert Wood Johnson Foundation (RWJF) and the Plexus Institute (Plexus) today announce results from an analysis of a multifaceted methicillin-resistant Staphylococcus aureus (MRSA) prevention program that employed positive deviance (PD), a novel approach to social and behavioral change, to trigger significant reductions in MRSA incidence ranging from 26 to 62 percent at participating hospitals.
Mirati Therapeutics, Inc. today presented data that demonstrated preliminary evidence of clinical activity from its investigational targeted tyrosine kinase inhibitor candidate, MGCD265, as part of the developmental therapeutics category at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago from May 29-June 2, 2015.
› Verified 7 days ago
Mrs. Penny Lynn Vogts, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2600 N Broadway St, Pittsburg, KS 66762 Phone: 620-232-3066 Fax: 620-231-5881 | |
Janet Zornes, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2600 N Broadway St, Pittsburg, KS 66762 Phone: 620-232-3066 | |
Mr. Rick M Baker, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1102 E Centennial Dr, Pittsburg, KS 66762 Phone: 620-232-0144 Fax: 620-235-3590 | |
Mrs. Megan Martin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1011 S Mount Carmel Pl, Pittsburg, KS 66762 Phone: 620-240-8035 Fax: 620-240-8034 | |
Ms. Laura E Sullivan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3303 Grand Oaks Ct, Pittsburg, KS 66762 Phone: 620-231-0843 | |
Robyn Harrell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2600 N Broadway St, Pittsburg, KS 66762 Phone: 620-232-3066 Fax: 620-231-5881 |